Dr. Mary Magno Mouracade, MD

  • Fort Myers, FL
  • Nephrologist
NPI1194776989PAC ID9234103409
Medicare services, 2024
2,117
Medicare patients, 2024
589
Part D claims, 2024
1,020
Hospital affiliations
2
Industry payments
$3,469
Practice address
4220 Executive Cir Ste 38, Fort Myers, FL 33916
Practice phone
Call (909) 806-0603
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

DaVita Fort Myers Dialysis

Dialysis Center - Independent · Fort Myers, Florida

See all 7 affiliations

Find Dr. Mouracade's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mary Magno Mouracade is a nephrologist in Fort Myers, Florida

Dr. Mouracade practices at DaVita Fort Myers Dialysis in Fort Myers, Florida.

Dr. Mouracade's NPI, 1194776989, was assigned on May 15, 2006. Dr. Mouracade graduated from Wake Forest School of Medicine in 1992. Dr. Mouracade holds Florida license ME65887.

NPI and contact details
Medicare PAC ID
9234103409
NPI enumeration date
May 15, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(909) 806-0603
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
60
Medical school graduation
1992

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mary Magno Mouracade practices at DaVita Fort Myers Dialysis in Fort Myers, Florida

Dr. Mouracade's primary practice is DaVita Fort Myers Dialysis, at 4220 Executive Cir Ste 38, Fort Myers, FL 33916 in Lee County. The practice phone is (909) 806-0603.

  • DaVita Fort Myers Dialysis
    4220 Executive Cir Ste 38, Fort Myers, FL 33916 · Lee CountyPhone(909) 806-0603

Source: Dmand AI Affiliation Data

Dr. Mary Magno Mouracade is affiliated with 6 sites of care and 1 medical group

Dr. Mouracade's primary practice is DaVita Fort Myers Dialysis in Fort Myers, Florida. Dr. Mouracade is also affiliated with Lee Memorial Hospital. The medical group on file is Associates in Nephrology. Dmand AI also links Dr. Mouracade to 1 more hospital, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Mouracade

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mary Magno Mouracade's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mouracade practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
DaVita Fort Myers DialysisAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Mouracade practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mary Magno Mouracade is one of 917 nephrologists in Florida

Nephrology is Dr. Mouracade's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mouracade is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mouracade's licenses on file in 3 states: Florida, Washington and North Carolina.

Specialties and state licenses

  • Nephrology, FloridaPrimaryLicense ME65887 · 1994 to 2027 · taxonomy 207RN0300X
  • Washington license2024 to 2025
  • North Carolina license2005 to 2008

Clinical focus

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, kidney disease and parathyroid gland disorder among the conditions Dr. Mouracade treats.

Nephrologists near Dr. Mouracade

Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mary Magno Mouracade billed Medicare for 2,117 services in 2024

CMS data shows 2,117 Medicare services from Dr. Mouracade across 14 procedure codes in 2024, for 589 Medicare patients. Medicare paid $171,359 for them.

Medicare services, 20242,117
Medicare patients589
Paid by Medicare$171,359
Procedure codes14

Dr. Mouracade's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,1462024: 1,40022%
Tests and treatments
2023: 6912024: 53622%
Other services
2023: 02024: 181

Where Dr. Mouracade's Medicare services took place, 2024

  • In an office1,17055%
  • In a facility94745%

Dr. Mouracade compared with the Florida median for nephrologists, 2024

  • Dr. Mouracade
  • Florida median
Medicare services
2,117vs 1,49042% above
Medicare patients
589vs 38752% above
Part D claims
799vs 93414% below

Medians across 882 nephrologists in Florida with Dmand AI profiles that report each measure.

Dr. Mouracade's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mouracade

Need commercial claims for Dr. Mouracade?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mouracade and other nephrologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mary Magno Mouracade treated 589 Medicare patients in 2024, average age 75

CMS counts 589 Medicare patients who saw Dr. Mouracade in 2024. The largest group is 75 to 84, with 231 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 4.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mouracade's median patient age at 73, with 51% women.

Medicare patients, 2024589
Average age75
Average risk score4.21
Also on Medicaid17%

Dr. Mouracade's Medicare patients by age, 2024

Dr. Mouracade's Medicare patients by sex, 2024

  • Women28248%
  • Men30752%

Chronic conditions among Dr. Mouracade's Medicare patients, 2024

  1. Chronic kidney disease75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Ischemic heart disease59%
  5. Arthritis56%
  6. Diabetes56%
  7. Heart failure56%
  8. Atrial fibrillation42%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mouracade's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women51%
  • Men49%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mary Magno Mouracade wrote 1,020 Medicare Part D claims in 2024

In 2024, Dr. Mouracade wrote 1,020 Medicare Part D claims for 208 patients. 88% of them were for generic drugs. CMS names the drug for 799 of them, across 27 drugs with 11 or more claims each, at $120,080 in total drug cost. In 2023, CMS named 731 claims across 21 drugs.

Part D claims, 20241,020
Drugs named by CMS27
Total drug cost$120,080
Part D patients208

Dr. Mouracade's Part D claims by kind of drug, 2024

  • Generic902 claims88%
  • Brand-name118 claims12%

Dr. Mouracade's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mouracade's Part D claims, 2024

  • Antibiotics2%20 of 1,020 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7312024: 7999%

Drugs named by CMS: 27 in 2024, 21 in 2023.

See all prescribing by Dr. Mouracade

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mary Magno Mouracade offers telehealth to Medicare patients

Dr. Mouracade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mouracade as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find nephrologists like Dr. Mouracade by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mary Magno Mouracade received $3,469 in industry payments from 2016 to 2025

CMS Open Payments shows 134 general payments to Dr. Mouracade from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $482.

General payments to Dr. Mouracade by program year, 2016 to 2025

General payments to Dr. Mouracade by kind, 2016 to 2025

$3.5Kin total
  • Food and beverage$3,44799%
  • Education$221%

Companies that paid Dr. Mouracade the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mouracade

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mary Magno Mouracade has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Mouracade, most recently Gulfshore Life Magazine: Top Doctors in 2018.

Awards and honors for Dr. Mouracade

  1. 2018
    • Gulfshore Life Magazine: Top Doctors
  2. Undated
    • Checkbook Top Doc

Source: Dmand AI Professional Profile Data

Dr. Mary Magno Mouracade graduated from Wake Forest School of Medicine

Dr. Mouracade graduated from Wake Forest School of Medicine in 1992. Dr. Mouracade is a member of ACP.

  1. Medical schoolWake Forest School of Medicine
  2. Board certified in internal medicineAmerican Board of Internal Medicine
  3. Board certified in nephrologyAmerican Board of Internal Medicine
  4. Board certified in addiction medicineAmerican Board of Preventive Medicine
  5. Board certified in integrative medicineBoard Certification by APBS

Source: Dmand AI Professional Profile Data

Dr. Mary Magno Mouracade accepts plans from 18 insurance carriers

Dr. Mouracade is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Plan types Dr. Mouracade accepts, by number of carriers

  1. PPO13
  2. Medicare11
  3. HMO10
  4. POS6
  5. EPO5
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Mary Magno Mouracade's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mary Magno Mouracade

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mary Magno Mouracade's NPI number?

Dr. Mary Magno Mouracade's NPI number is 1194776989. It was assigned on May 15, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mary Magno Mouracade?

Dr. Mary Magno Mouracade is a nephrologist in Fort Myers, Florida. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).

Where does Dr. Mary Magno Mouracade practice?

Dr. Mouracade practices at 4220 Executive Cir Ste 38, Fort Myers, FL 33916. Dr. Mouracade's primary practice is DaVita Fort Myers Dialysis in Fort Myers, Florida. Dmand AI also links Dr. Mouracade to 1 hospital, 2 dialysis centers and 1 group practice or clinic.

What is Dr. Mary Magno Mouracade's office phone number?

The practice phone on file for Dr. Mouracade is (909) 806-0603.

What is Dr. Mary Magno Mouracade's medical license number?

Dr. Mouracade holds Florida license ME65887, one of the licenses on file in 3 states.

Which states has Dr. Mary Magno Mouracade been licensed in?

Dmand AI has state licenses on file for Dr. Mouracade in Florida (1994 to 2027), Washington (2024 to 2025) and North Carolina (2005 to 2008).

Which hospitals is Dr. Mary Magno Mouracade affiliated with?

Dr. Mouracade is affiliated with Lee Memorial Hospital. Dmand AI links Dr. Mouracade to 1 more hospital.

What medical group is Dr. Mary Magno Mouracade part of?

Dr. Mouracade is linked to Associates in Nephrology.

Does Dr. Mary Magno Mouracade accept Medicare?

Yes. CMS data shows Dr. Mouracade billed Medicare for 2,117 services in 2024, and Dr. Mouracade accepts Medicare assignment.

Does Dr. Mary Magno Mouracade offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mouracade as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Mary Magno Mouracade see?

CMS counts 589 Medicare patients who saw Dr. Mouracade in 2024, with an average age of 75.

Is Dr. Mary Magno Mouracade board certified?

Yes. Dr. Mouracade is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. Mary Magno Mouracade bill to Medicare?

In 2024, Dr. Mouracade's most billed Medicare services were hospital inpatient care (99232), office visit, established patient (99214) and office visit, established patient (99213).

Where did Dr. Mary Magno Mouracade go to medical school?

Dr. Mouracade graduated from Wake Forest School of Medicine in 1992.

What drugs does Dr. Mary Magno Mouracade prescribe most?

In 2024 Medicare Part D data, Dr. Mouracade's most prescribed drugs by claims were Calcitriol, Amlodipine Besylate and Losartan Potassium.

Has Dr. Mary Magno Mouracade received payments from drug or device companies?

CMS Open Payments shows $3,469 in general payments to Dr. Mouracade from 27 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Mary Magno Mouracade been practicing?

Dr. Mouracade graduated from medical school in 1992, 34 years ago.

What insurance does Dr. Mary Magno Mouracade accept?

Dr. Mouracade is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Selling to nephrology practices?

See nephrologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)